article thumbnail

Phase I trial launches into oral drug for radioactive contamination

Drug Discovery World

A first-in-human clinical trial of an experimental oral drug for removing radioactive contaminants from inside the body has begun. The trial is testing the safety, tolerability and processing in the body of escalating doses of the investigational drug product HOPO 14-1 in healthy adults.

article thumbnail

Multiple indicators of wastewater contamination to shellfish farms

Scienmag

A recent study by researchers at the Dauphin Island Sea Lab and the University of South Alabama, in collaboration with the U.S. Food and Drug Administration, tested multiple indicators of wastewater contamination to identify potential sources of contamination […].

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

SnoreStop NasoSpray is Voluntarily Recalled by Green Pharmaceuticals Due to Microbial Contamination

XTalks

The US Food and Drug Administration (FDA) found the 0.3 FL OZ (9 mL) nasal spray bottles to be contaminated with the bacteria, Providencia rettgeri. Previous and emerging research on this bacterium has associated it with intrinsic multi-drug resistance and nosocomial infections (also referred to as hospital-acquired infections).

article thumbnail

STAT+: Pharmalittle: FDA slams company recalling eye drops over manufacturing issues; U.S. funds massive Alzheimer’s research database

STAT News

Your tips and insights help the world go around… Global Pharma Healthcare, whose eye drops have been linked to dozens of serious reactions, failed to follow numerous procedures to ensure its products did not become contaminated , according to a U.S. Food and Drug Administration inspection report obtained by STAT.

article thumbnail

This week in drug discovery (15-19 May)

Drug Discovery World

In-human studies have been initiated to test treatments for Parkinson’s disease, radioactive contamination, Dravet Syndrome, influenza and inflammatory diseases. The post This week in drug discovery (15-19 May) appeared first on Drug Discovery World (DDW).

article thumbnail

New research will improve safety and quality of Heparin

Scienmag

Credit: University of Nottingham A new method to analyse the blood thinning drug Heparin has been developed that can pinpoint contaminants more accurately and quickly, providing greater quality control and safety.

article thumbnail

DDW event focusses on rAAVs and long-read nanopore sequencing

Drug Discovery World

This webinar will detail how Oxford Nanopore evaluated long-read nanopore sequencing as a comprehensive and sensitive QC method for rAAVs which is supporting internal research activities at AstraZeneca. The post DDW event focusses on rAAVs and long-read nanopore sequencing appeared first on Drug Discovery World (DDW).

DNA 98